Zometa’s Survival Benefit ConfirmedByElizabeth WhittingtonDecember 15th 2011Women receiving a supportive care drug to reduce bone loss caused by breast cancer treatment may actually be getting more than that—improved survival and lower risk of metastatic recurrence.
Afinitor impresses in advanced hormone-positive breast cancersByElizabeth WhittingtonDecember 8th 2011
Breast Cancer and the Environment Report offers research roadmapByElizabeth WhittingtonDecember 7th 2011
Pet ProjectByPaul J. WeberNovember 9th 2011The benefits of pet-patient interaction suggest it's more than "alternative therapy."